全文获取类型
收费全文 | 1282047篇 |
免费 | 73680篇 |
国内免费 | 1420篇 |
专业分类
耳鼻咽喉 | 16559篇 |
儿科学 | 42038篇 |
妇产科学 | 32293篇 |
基础医学 | 175539篇 |
口腔科学 | 31397篇 |
临床医学 | 109160篇 |
内科学 | 241194篇 |
皮肤病学 | 25468篇 |
神经病学 | 99715篇 |
特种医学 | 52950篇 |
外国民族医学 | 201篇 |
外科学 | 198443篇 |
综合类 | 24745篇 |
现状与发展 | 1篇 |
一般理论 | 266篇 |
预防医学 | 94068篇 |
眼科学 | 28022篇 |
药学 | 97628篇 |
8篇 | |
中国医学 | 3496篇 |
肿瘤学 | 83956篇 |
出版年
2021年 | 8242篇 |
2019年 | 8333篇 |
2018年 | 34483篇 |
2017年 | 27422篇 |
2016年 | 31625篇 |
2015年 | 12700篇 |
2014年 | 16773篇 |
2013年 | 23800篇 |
2012年 | 38670篇 |
2011年 | 54866篇 |
2010年 | 38543篇 |
2009年 | 30381篇 |
2008年 | 51876篇 |
2007年 | 57407篇 |
2006年 | 34028篇 |
2005年 | 34576篇 |
2004年 | 34725篇 |
2003年 | 35081篇 |
2002年 | 31700篇 |
2001年 | 60780篇 |
2000年 | 62532篇 |
1999年 | 51484篇 |
1998年 | 12843篇 |
1997年 | 11434篇 |
1996年 | 11280篇 |
1995年 | 10591篇 |
1994年 | 9625篇 |
1993年 | 9077篇 |
1992年 | 38109篇 |
1991年 | 36619篇 |
1990年 | 36076篇 |
1989年 | 34574篇 |
1988年 | 31096篇 |
1987年 | 30222篇 |
1986年 | 28423篇 |
1985年 | 26655篇 |
1984年 | 19355篇 |
1983年 | 16289篇 |
1982年 | 8959篇 |
1979年 | 17201篇 |
1978年 | 11530篇 |
1977年 | 10284篇 |
1976年 | 8953篇 |
1975年 | 10107篇 |
1974年 | 11750篇 |
1973年 | 11357篇 |
1972年 | 10825篇 |
1971年 | 10139篇 |
1970年 | 9333篇 |
1969年 | 9008篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
Ohne Zusammenfassung 相似文献
64.
K P Sylvester S R Desai A U Wells D M Hansell M Awogbade S L Thein A Greenough 《The European respiratory journal》2006,28(4):832-838
The aim of this study was to determine whether patients with sickle cell disease (SCD) in steady state had pulmonary abnormalities seen on high-resolution computed tomography (HRCT) and whether any abnormalities correlated with contemporaneously diagnosed lung function abnormalities. A subsidiary question was whether the results of a noninvasive measure of haemolysis (end-tidal carbon monoxide (ETCO) levels) correlated with pulmonary function abnormalities. Thirty three patients with SCD, median (range) age 36 yrs (17-67 yrs) were examined. The degree of lobar volume loss and ground-glass opacification and prominence of central vessels on HRCT were quantitatively assessed. Pulmonary function was assessed by measurements of lung volumes, spirometry, gas transfer and oxygen saturation. ETCO levels were measured using an end-tidal CO monitor. Forced expiratory volume in one second (FEV1), forced vital capacity and total lung capacity significantly correlated with HRCT findings, particularly lobar volume loss. ETCO levels significantly negatively correlated with FEV1, vital capacity measured using a plethysmograph, specific airway conductance and arterial oxygen saturation measured by pulse oxymetry. In conclusion, the present results suggest that high-resolution computed tomography noninvasive assessment of haemolysis might be useful to identify sickle cell disease patients with respiratory function impairment. 相似文献
65.
J Müller-Quernheim K I Gaede E Fireman G Zissel 《The European respiratory journal》2006,27(6):1190-1195
An increase in chronic beryllium disease (CBD) has been suggested due to higher industrial use of beryllium alloys. Since occupational CBD is a perfect phenocopy of sarcoidosis, it might be misdiagnosed as sarcoidosis. In the current it was hypothesised that CBD exists in cohorts of sarcoidosis patients. In a prospective case study, sarcoidosis patients were evaluated for potential beryllium exposure. In those patients in whom beryllium exposure was confirmed and beryllium hypersensitivity demonstrated, the diagnosis of sarcoidosis was rejected and corrected to CBD. In 84 patients seen for re-evaluation or making a diagnosis of sarcoidosis, beryllium exposure was recognised and a diagnosis of CBD was made in 34 out of 84 patients. The time lag between clinical diagnosis of sarcoidosis and the final diagnosis of CBD ranged 0-18 yrs (median 3 yrs) and the mean (range) age at time of diagnosis of CBD was 43.9(25-80) yrs. Beryllium-contaminated workplaces causing disease encompassed a wide spectrum of industries and technical trades in which beryllium-exposure is generally not perceived as a health hazard. In conclusion, chronic beryllium disease still belongs to the spectrum of differential diagnoses of granulomatous disorders. 相似文献
66.
67.
68.
69.
70.
Sami S Zoghbi H Umesha Shetty Masanori Ichise Masahiro Fujita Masao Imaizumi Jeih-San Liow Jay Shah John L Musachio Victor W Pike Robert B Innis 《Journal of nuclear medicine》2006,47(3):520-527
18F-2beta-Carbomethoxy-3beta-(4-chlorophenyl)-8-(2-fluoroethyl)nortropane (18F-FECNT), a PET radioligand for the dopamine transporter (DAT), generates a radiometabolite that enters the rat brain. The aims of this study were to characterize this radiometabolite and to determine whether a similar phenomenon occurs in human and nonhuman primate brains by examining the stability of the apparent distribution volume in DAT-rich (striatum) and DAT-poor (cerebellum) regions of the brain. METHODS: Two rats were infused with 18F-FECNT and sacrificed at 60 min. Extracts of brain and plasma were analyzed by high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometric (LC-MS) techniques. Two human participants and 3 rhesus monkeys were injected with 18F-FECNT and scanned kinetically, with serial arterial blood analysis. RESULTS: At 60 min after the injection of rats, 18F-FECNT accumulated to levels about 7 times higher in the striatum than in the cortex and cerebellum. The radiometabolite was distributed at equal concentrations in all brain regions. The LC-MS techniques identified N-dealkylated FECNT as a major metabolite in the rat brain, and reverse-phase HPLC detected an equivalent amount of radiometabolite eluting with the void volume. The radiometabolite likely was 18F-fluoroacetaldehyde, the product expected from the N-dealkylation of 18F-FECNT, or its oxidation product, 18F-fluoroacetic acid. The distribution volume in the cerebellum increased up to 1.7-fold in humans between 60 and 300 min after injection and 2.0 +/- 0.1-fold (mean +/- SD; n = 3) in nonhuman primates between 60 and 240 min after injection. CONCLUSION: An 18F-fluoroalkyl metabolite of 18F-FECNT originating in the periphery confounded the measurements of DAT in the rat brain with a reference tissue model. Its uniform distribution across brain regions suggests that it has negligible affinity for DAT (i.e., it is an inactive radiometabolite). Consistent with the rodent data, the apparent distribution volume in the cerebellum of both humans and nonhuman primates showed a continual increase at late times after injection, a result that may be attributed to entry of the radiometabolite into the brain. Thus, reference tissue modeling of 18F-FECNT will be prone to more errors than analysis with a measured arterial input function. 相似文献